192389-29-0

Basic information

• Product Name: 1-Pyrrolidinecarboxylic acid, 2-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-5-methoxy-, 1,1-dimethylethyl ester, (2S)-
• CAS NO: 192389-29-0
• Molecular Formula: C27H39NO4Si
• Molecular Weight: 469.696
• Mol File: 192389-29-0.mol

Chemical Properties

• CAS DataBase Reference: 1-Pyrrolidinecarboxylic acid, 2-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-5-methoxy-, 1,1-dimethylethyl ester, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pyrrolidinecarboxylic acid, 2-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-5-methoxy-, 1,1-dimethylethyl ester, (2S)-(192389-29-0)
• EPA Substance Registry System: 1-Pyrrolidinecarboxylic acid, 2-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-5-methoxy-, 1,1-dimethylethyl ester, (2S)-(192389-29-0)

Safety Data

• Hazardous Substances Data: 192389-29-0(Hazardous Substances Data)

Upstream product

• 77-76-9 2,2-dimethoxy-propane 
• 192389-43-8 (5S)-1-(benzyloxycarbonyl)-5-[(tert-butyldiphenylsilyl)oxymethyl]-2-hydroxypyrrolidine 
• 7149-65-7 ethyl (S)-pyroglutamate 
• 98-79-3 L-Pyroglutamic acid 
• 4931-66-2 methyl (S)-pyroglutamate 
• 17342-08-4 (S)-Pyroglutaminol 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 138629-30-8 (S)-tert-butyl 2-((tert-butyldiphenylsilyloxy)methyl)-5-oxopyrrolidine-1-carboxylate 
• 132974-83-5 (5S)-5-[[(tert-butyldiphenylsilyl)oxy]methyl]pyrrolidin-2-one 
• 24424-99-5 di-tert-butyl dicarbonate 
• 149-73-5 trimethyl orthoformate 

Downstream Products

• 181705-70-4 (5S,2'S,5'S)-5-[1'-(tert-butoxycarbonyl)-5'-(tert-butyldiphenylsilyloxymethyl)pyrrolidin-2'-yl]-2(5H)-furanone 
• 192389-30-3 (2S,5R)-tert-butyl 2-((tert-butyldiphenylsilyloxy)methyl)-5-cyanopyrrolidine-1-carboxylate 
• 192389-31-4 (2S,5S)-tert-butyl 2-((tert-butyldiphenylsilyloxy)methyl)-5-cyanopyrrolidine-1-carboxylate 
• 192389-33-6 (2S,5S,1'S)-N-tert-butoxycarbonyl-5-(tert-butyldiphenylsilyloxy)methyl-2-(1'-hydroxy-3'-trimethylsilyl)-prop-2'-ynyl-pyrrolidine 
• 192389-32-5 (2S,5S,1'R)-N-tert-butoxycarbonyl-5-(tert-butyldiphenylsilyloxy)methyl-2-(1'-hydroxy-3'-trimethylsilyl)-prop-2'-ynyl-pyrrolidine 
• 192389-42-7 (2S,5S,2'S,5'S,2''S,5''S)-N,N''-di-tert-butoxycarbonyl-2,5''-bis-[(tert-butyldiphenylsilyloxy)methyl]-dodecahydro-terpyrrole 
• 192389-46-1 C₅₇H₈₁N₅O₉SSi₂ 
• 192389-41-6 (2'S,5'S,2''S,5''S,1R,4S)-4,7-bis-[N'-tert-butoxycarbonyl-5'-(tert-butyldiphenylsilyloxy)methyl]-pyrrolidin-2'-yl-4-azido-butan-1-ol 
• 192389-40-5 (2'S,5'S,2''S,5''S,4R,7R)-4,7-bis-[N'-tert-butoxycarbonyl-5'-(tert-butyldiphenylsilyloxy)methyl]-pyrrolidin-2'-yl-(2,2-dioxo-1,3-dioxa)-thiepane 
• 192389-39-2 (2'S,5'S,2''S,5''S,4R,7R)-4,7-bis-[N'-tert-butoxycarbonyl-5'-(tert-butyldiphenylsilyloxy)methyl]-pyrrolidin-2'-yl-(2-oxo-1,3-dioxa)-thiepane 
• 782496-05-3 (2'S,5'S,2''S,5''S,1R,4R)-1,4-bis-[N'-tert-butoxycarbonyl-5-(tert-butyldiphenylsilyloxy)methyl]-pyrrolidin-2'-yl-1-(trimethylsilyl)oxy-2-butyn-4-ol 
• 192389-27-8 (2'S,5'S,2''S,5''S,1R,4R)-1,4-bis-[N'-tert-butoxycarbonyl-5'-(tert-butyldiphenylsilyloxy)methyl]-pyrrolidin-2'-yl-2-butyne-1,4-diol 
• 192389-38-1 (2'S,5'S,2''S,5''S,1R,4R)-1,4-bis-[N'-tert-butoxycarbonyl-5'-(tert-butyldiphenylsilyloxy)methyl]-pyrrolidin-2'-yl-butane-1,4-diol 
• 192389-34-7 (2S,5S,1'R)-N-tert-butoxycarbonyl-5-(tert-butyldiphenylsilyloxy)methyl-2-[1'-(trimethylsilyl)oxy]-prop-2'-ynyl-pyrrolidine 

Relevant articles and documents

STRUCTURAL MIMETICS OF PROLINE-RICH PEPTIDES AND THE PHARMACEUTICAL USE THEREOF

The invention relates to compounds of general formula (I), which can be used particularly as structural mimetics of proline-rich peptides and are therefore capable of binding PRM binding domains (proline-rich motif binding domains) of proteins. The invention also relates to the use of said compounds as pharmaceutical active agents and the use of these pharmaceutical active agents for treating bacterial diseases, neurodegenerative diseases and tumours.

Diastereoselective synthesis of 4,5′-bis-proline compounds via reductive dimerization of N-acyloxyiminium ions

A short, practical synthesis of novel, unsymmetrical 4,5′-bis-proline compounds has been achieved, highlighted by the application of an unprecedented samarium diiodide-driven regio- and diastereocontrolled reductive dimerization of N-acyloxyiminium ions generated from readily available 2-methoxy-5- silyloxymethyl-N-Boc pyrrolidines. The title proline dimers proved to be pertinent metal-free catalysts in aldol and Mannich reactions.

Stereoselective synthesis of a terpyrrolidine unit, a potential building block for anion recognition

The first stereoselective synthesis of a trans-threo-trans-threo-trans terpyrrolidine was achieved. A bidirectional strategy involving double acetylide coupling of two trans-N-BOC-pyrrolidine-aldehydes 3, epimerisation-free hydrogenation and ring closure via a seven-membered cyclic sulfate gives access to the terpyrrolidine scaffold.

A versatile synthesis of a β-turn peptidomimetic scaffold: An approach towards a designed model antagonist of the tachykinin NK-2 receptor

A general and stereocontrolled synthesis of an azabicyclo[4.3.0]nonane amino acid template with an appended substitutent at C-5 was developed. The approach allows for stereochemical and functional variations that extend the utility of these rigid amino acid motifs as peptidomimetics. The synthesis of a weakly active but specific NK-2 receptor antagonist is described.

The synthesis of 4'-t-butylcarbamyl- and 4'-p-toluenesulphonamidyl-2',3'- dideoxy pyrimidine nucleoside analogues

The preparation of 4'-t-butylcarbamyl-2',3'-dideoxy thymidine, uridine and 5-ethyl uridine nucleoside analogues and 4'-p-toluenesulphonamidyl-2',3'- dideoxy thymidine and 5-ethyl uridine nucleoside analogues from L- pyroglutamic acid is reported.